Tuija Javanainen

Levels of growth differentiation factor 15 and early mortality risk stratification in cardiogenic shock.

A. Mebazaa, R. Jurkko, A. Kimmoun, 2019, Journal of cardiac failure.

Prognostic impact of baseline and residual SYNTAX scores in cardiogenic shock

M. Nieminen, R. Jurkko, V. Harjola, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prolonged corrected QT interval is associated with short-term and long-term mortality in critically ill patients: results from the FROG-ICU study

A. Mebazaa, R. Jurkko, E. Gayat, 2019, Intensive Care Medicine.

Predictive value of the baseline electrocardiogram ST‐segment pattern in cardiogenic shock: Results from the CardShock Study

M. Nieminen, R. Jurkko, V. Harjola, 2018, Annals of Noninvasive Electrocardiology.

Acute Heart Failure Management

A. Mebazaa, R. Cinotti, K. Čerlinskaitė, 2018, Korean circulation journal.

Acute Heart Failure Management Cerlinskaite , Kamile 2018-06

A. Mebazaa, R. Cinotti, K. Čerlinskaitė, 2022 .

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

A. Mebazaa, A. Bergmann, P. Jorens, 2021, Intensive Care Medicine.

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock

A. Mebazaa, R. Jurkko, J. Parissis, 2019, PloS one.

Prevalence, Temporal Evolution, and Impact on Survival of Ventricular Conduction Blocks in Patients With Acute Coronary Syndrome and Cardiogenic Shock.

R. Jurkko, T. Nieminen, V. Harjola, 2018, The American journal of cardiology.

Title: Prevalence, Temporal Evolution and Impact on Survival of Ventricular Conduction Blocks in Patients with Acute Coronary Syndrome and Cardiogenic Shock

R. Jurkko, T. Nieminen, J. Masip, 2018 .